Welcome to Part 1 of our Peptide Series, where we break down the science behind today’s most talked-about compounds–starting with retatrutide.
In this episode, we dive into the mechanism of action of retatrutide, the first GLP-1, GIP, and glucagon triple agonist, and why it represents a major shift in obesity pharmacology.
We cover:
This episode is your mechanism-first foundation for understanding where peptide-based fat loss is headed.
1:1 COACHING:
SHOP MY NEW 'NUTRITION NAVIGATED' E-BOOK!
STRENGTH & HYPERTROPHY TRAINING PROGRAM:
MY SOCIALS:
CONTACT ME:
STUDIES/CLINICAL TRIALS:
